FDA Issues Warning Letter to Aspen Bioph
The U.S. Food and Drug Administration (FDA) issued a Warning Letter to Aspen Biopharma Labs
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
